Clinical & Experimental Metastasis

, Volume 22, Issue 1, pp 39–46 | Cite as

Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow

  • Neslihan Cabioglu
  • Aysegul Sahin
  • Michele Doucet
  • Ekrem Yavuz
  • Abdullah Igci
  • Engin O.Yildirim
  • Esin Aktas
  • Sema Bilgic
  • Bayram Kiran
  • Gunnur Deniz
  • Janet E. Price


Interactions between the CXCR4 chemokine receptor in breast cancer cells and the ligand CXCL12/SDF-1α are thought to play an important role in breast cancer metastases. In this pilot study, CXCR4 expression along with other biomarkers including HER2-neu and EGFR, were measured in primary tumor samples of patients with operable breast cancer to test whether any of these biomarkers alone and in combination could indicate breast cancer with high likelihood of metastasizing to bone marrow. Cytokeratin (CK) positive cells in bone marrow were identified by flow-cytometry following enrichment with CK 7/8 antibody-coupled magnetic beads. Primary tumors (n = 18) were stained with specific antibodies for CXCR4, HER2-neu, EGFR, and PCNA using an indirect avidin–biotin horseradish peroxidase method. The majority of the patients had T2/T3 tumors (72%), or lymph node involvement (67%) as pathologic characteristics that were more indicative of high-risk breast cancer. High CXCR4 cytoplasmic expression was found in 7 of 18 patients (39%), whereas 6 of 18 patients (33%) were found to have CK positivity in bone marrow. The median number of CK+ cells was 236 (range, 20–847) per 5 × 104 enriched BM cells. The presence of CK+ cells in bone marrow was found to be associated with increased expression of CXCR4 alone or in addition to EGFR and/or HER2-neu expression (P = 0.013, P = 0.005, and P = 0.025, respectively) in primary tumors. Furthermore, three patients with high CK positivity (>236 CK+ per 5 × 104 enriched bone marrow cells) in bone marrow exclusively expressed high levels of CXCR4 with EGFR/HER2-neu (P = 0.001). Our data suggest that high CXCR4 expression in breast cancer may be a potential marker in predicting isolated tumor cells in bone marrow. CXCR4 coexpression with EGFR/HER2-neu might further predict a particular subset of patients with high CK positivity in bone marrow.


bone marrow micrometastases breast cancer chemokine receptors CXCR4 EGFR HER2/neu 



bone marrow




epidermal growth factor receptor


estrogen receptor


histologic grade


isolated tumor cell


phosphate buffered saline


proliferating cell nuclear antigen


progesteron receptor


tumor node metastasis


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Diel, IJ, Costa, SD, Holle, R,  et al. 1996Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal statusJ Natl Cancer Inst88165264Google Scholar
  2. 2.
    Braun, S, Pantel, K, Müller, P,  et al. 2000Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancerN Engl J Med34352533CrossRefGoogle Scholar
  3. 3.
    Solomayer, EF, Diel, IJ, Salanti, G,  et al. 2001Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patientsClin Cancer Res741028Google Scholar
  4. 4.
    Braun, S, Cevatli, BS, Assemi, C,  et al. 2001Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapyJ Clin Oncol19146875PubMedGoogle Scholar
  5. 5.
    Gerber, B, Krause, A, Müller, H,  et al. 2001Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factorsJ Clin Oncol1996071PubMedGoogle Scholar
  6. 6.
    Naume, B, Borgen, E, Kvalheim, G,  et al. 2001Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristicsClin Cancer Res7412229PubMedGoogle Scholar
  7. 7.
    Menard, S, Squicciarini, P, Luini, A,  et al. 1994Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic featuresBr J Cancer6911269PubMedGoogle Scholar
  8. 8.
    Schindlbeck, C, Janni, W, Shabani, N,  et al. 2004Comparative analysis between the HER2 status primary breast cancer tissue and the detection of isolated tumor cells in the bone marrowBreast Cancer Res Treat876574CrossRefPubMedGoogle Scholar
  9. 9.
    Muller, A, Homey, B, Soto, H,  et al. 2001Involvement of chemokine receptors in breast cancer metastasesNature410506CrossRefPubMedGoogle Scholar
  10. 10.
    Smith, MCP, Luker, KE, Garbow, JR,  et al. 2004CXCR4 regulates growth of both primary and metastatic breast cancerCancer Res64860412PubMedGoogle Scholar
  11. 11.
    Geminder, H, Sagi-Assif, O, Goldberg, L,  et al. 2001A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastomaJ Immunol167474757PubMedGoogle Scholar
  12. 12.
    Russell, HV, Hicks, J, Okcu, MF, Nuchtern, JG 2004CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastasesJ Pediatr Surg39150611CrossRefPubMedGoogle Scholar
  13. 13.
    Shen, W, Bendall, LJ, Gottlieb, DJ, Bradstock, K 2001The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrowExp Hematol29143947CrossRefPubMedGoogle Scholar
  14. 14.
    Taichman, RS, Cooper, C, Keller, ET,  et al. 2002Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to boneCancer Res6218327PubMedGoogle Scholar
  15. 15.
    Braun, S, Schlimock, G, Heumos, I,  et al. 2001Erb2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patientsCancer Res6118905PubMedGoogle Scholar
  16. 16.
    Cabioglu N, Miller C, Parikh N et al. Crosstalk between CXCR4 and HER2-neu in breast cancer: transactivation of HER2-neu by stromal derived factor-1 alpha through Src kinase activation. Proceedings of 95th American Association for Cancer Research, 95th Annual Meeting, 2004; p. 907.Google Scholar
  17. 17.
    Bloom, HJG, Richardson, WW 1957Histologic grading and prognosis in breast cancerBr J Cancer1135977PubMedGoogle Scholar
  18. 18.
    Martin, VM, Siewert, C, Scharl, A,  et al. 1998Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACSExp Hematol2625264PubMedGoogle Scholar
  19. 19.
    Cabioglu, N, Igci, A, Yildirim, EO,  et al. 2002An ultrasensitive tumor enriched flow-cytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancerAm J Surg1844147CrossRefPubMedGoogle Scholar
  20. 20.
    Cabioglu N, Yazici MS, Arun BK et al. Expression of CXCR4 predicts lymph node metastasis in early breast cancer. Annual Meeting Proceedings; the 40th Annual Meeting of the American Society of Clinical Oncology, 2004, p. 9525.Google Scholar
  21. 21.
    Chen, B, Brekel, MWM, Buschers, W,  et al. 2003Validation of tissue array technology in head and neck squamous cell carcinomaHead Neck2592230CrossRefPubMedGoogle Scholar
  22. 22.
    Niu, Y, Fu, X, Lv, A,  et al. 2002Potential markers predicting distant metastasis in axillary node-negative breast carcinomaInt J Cancer9875460CrossRefPubMedGoogle Scholar
  23. 23.
    Suo, Z, Risberg, B, Kalsson, MG,  et al. 2002EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survivalJ Pathol1961725CrossRefPubMedGoogle Scholar
  24. 24.
    Tsutsui, S, Ohno, S, Murakami, S,  et al. 2003Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancerSurgery13321921CrossRefPubMedGoogle Scholar
  25. 25.
    Li, YM, Pan, Y, Wei, Y,  et al. 2004Upregulation of CXCR4 is essential for HER2-mediated tumor metastasisCancer Cell645969CrossRefPubMedGoogle Scholar
  26. 26.
    Braun, S, Hepp, F, Sommer, HL, Pantel, K 1999Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual diseaseInt J Cancer (Pred Oncol)8415CrossRefGoogle Scholar
  27. 27.
    Forus, A, Høifødt, HK, Øverli, GET,  et al. 1999Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspiratesJ Clin Pathol Mol Pathol526874Google Scholar
  28. 28.
    Schlimock, G, Riethmuller, G 1990Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrowSemin Cancer Biol120715PubMedGoogle Scholar
  29. 29.
    Schlimock, G, Funke, I, Bock, B,  et al. 1990Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significanceJ Clin Oncol88317PubMedGoogle Scholar
  30. 30.
    Zeelenberg, IS, Ruuls-Van Stalle, L, Roos, E 2003The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastasesCancer Res6338339PubMedGoogle Scholar
  31. 31.
    Janni, W, Gastroph, S, Hepp, F,  et al. 2000Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinomaCancer8822529CrossRefPubMedGoogle Scholar
  32. 32.
    Naume, B, Boregen, E, Nesland, JM,  et al. 1998Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic seperationInt J Cancer7855660CrossRefPubMedGoogle Scholar
  33. 33.
    Kasimir-Bauer, S, Oberhoff, C, Sliwinska, K,  et al. 2001Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?Breast Cancer Res Treat6912332CrossRefPubMedGoogle Scholar
  34. 34.
    Racilla, E, Euhus, D, Weiss, AJ,  et al. 1998Detection and characterization of carcinoma cells in the bloodProc Natl Acad Sci USA95458994CrossRefPubMedGoogle Scholar
  35. 35.
    Molnar, B, Ladanyi, A, Tanko, L,  et al. 2001Correspondence re: circulating tumor cell clusters in the peripheral blood of colorectal cancer patientsClin Cancer Res740805PubMedGoogle Scholar
  36. 36.
    Weihrauch, MR, Skibowski, E, Draube, A,  et al. 2002Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignanciesClin Exp Metast1961721CrossRefGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Neslihan Cabioglu
    • 1
  • Aysegul Sahin
    • 2
  • Michele Doucet
    • 1
  • Ekrem Yavuz
    • 3
  • Abdullah Igci
    • 4
  • Engin O.Yildirim
    • 5
  • Esin Aktas
    • 5
  • Sema Bilgic
    • 5
  • Bayram Kiran
    • 5
  • Gunnur Deniz
    • 5
  • Janet E. Price
    • 1
  1. 1.Department of Cancer BiologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  2. 2.Department of PathologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  3. 3.Department of PathologyIstanbul Faculty of MedicineIstanbulTurkey
  4. 4.Department of General SurgeryIstanbul Faculty of MedicineIstanbulTurkey
  5. 5.Institute of Experimental Medical ResearchInstanbul UniversityIstanbulTurkey

Personalised recommendations